Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$4,467,561
-$981,784 QoQ
Shares Held
185,530
-4.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#641
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $202,731,943 across 16 Drug Manufacturers - General names. PFE ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
348,943 | $88,621,053 | |
| 2 | LLY |
ELI LILLY & Co
|
27,892 | $33,454,503 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,656 | $28,739,795 | |
| 4 | AMGN |
Amgen Inc
|
47,244 | $17,107,996 | |
| 5 | ABBV |
AbbVie Inc.
|
51,835 | $13,043,758 | |
| 6 | AZN |
Astrazeneca PLC
|
32,878 | $6,234,325 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
106,605 | $6,142,579 | |
| 8 | PFE |
Pfizer Inc
This page
|
185,530 | $4,467,561 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,467,561 | 185,530 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $5,449,345 | 194,065 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $5,188,661 | 208,380 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,496,748 | 215,728 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $7,050,712 | 290,871 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $7,745,702 | 305,671 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $8,271,336 | 311,773 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $9,348,082 | 323,016 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $4,448,371 | 158,984 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,580,191 | 165,052 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $5,707,063 | 172,055 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $6,368,307 | 173,618 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,096,302 | 173,929 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,563,176 | 186,635 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,283,154 | 189,286 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,899,307 | 188,810 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,144,330 | 195,950 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,248,504 | 207,426 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,052,528 | 210,475 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $8,265,343 | 211,066 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $7,586,452 | 209,397 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $7,829,559 | 212,702 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,648,087 | 208,395 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,940,449 | 212,246 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,182,944 | 220,066 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||